Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin

Chinese Medical Journal

Volumn 117, Issue 11, 2004, Pages 1620-1624

  Lü, Han Jing ^a   Qiu, Zhong Min ^a   Wei, Wei Li ^a   Yu, Li ^a   Liu, Rui Lin ^a   Zhang, Min ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Airway responsiveness; Eosinophilic airway inflammation; Phosphodiesterase inhibitor

Indexed keywords

AMINOPHYLLINE; CAPSAICIN; CILOMILAST; METHACHOLINE; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG RESPONSE; GUINEA PIG; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MALE; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; COUGH; CYCLIC AMP; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; MALE; OVALBUMIN; PHOSPHODIESTERASE INHIBITORS;

EID: 10244278057     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Niimi A, Amitani R, Suzuki K, et al. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11: 1064-1069.
2. Brightling CE, Symon FA, Birring SS, et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003;58:528-532.
3. Underwood DC, Osborn RR, Novak LB, et al. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 1993;264:609-615.
4. Raeburn D, Underwood SL, Lewis SA, et al. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type 4 inhibitor. Br J Pharmacol 1994;113:1423-1431.
5. Danahay H, Broadley KJ. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration. Br J Pharmacol 1998;120:289-297.
6. Kanehiro A, Ikemura T, Makela MJ, et al. Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 2001;163:173-184.
7. 4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects. Eur Respir J 1997;10:1008-1014.
8. Muraki M, Tohda Y, Sugihara R, et al. The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea-pigs actively sensitized with ovalbumin. J Pharm Pharmacol 1994;46:883-886.
9. Liu Q, Fujimura M, Tachibana H, et al. Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin Exp Allergy 2001;31:474-484.
10. Qiu Z, Liu Q, Guo D, et al. The effect of bradykinin B2 receptor antagonist on cough reactivity in a sensitized guinea pig model. Chin J Tuberc Respir Dis (Chin) 2002;25:74-77.
11. Qiu ZM, Lü HJ, Yang ZM, et al. The Relationship between cough response and airway inflammation in guinea pigs sensitized and challenged with ovalbumin. Chin J Pathophysiol (Chin) 2003;19:1488-1492.
12. Fawcett L, Baxendale R, Stacey P, et al. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci U S A 2000;97: 3702-3707.
13. Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-818.
14. Weston MC, Anderson N, Peachell PT. Effect of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 1997;121:287-295.
15. Kaneko T, Alvarez R, Ueki IF, et al. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell Signal 1995;7:527-534.
16. Essayan DM, Kagey-Sobotka A, Lichtenstein LM, et al. Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clones. Biochem Pharmacol 1997;53: 1055-1060.
17. Sato Y, Sato S, Yamamoto T, et al. Phosphodiesterase type 4 inhibitor reduces the retention of polymorphonuclear leukocytes in the lung. Am J Physiol Lung Cell Mol Physiol 2002;282:L1376-L1381.
18. 4) inhibitor SB 207499 (Ariflo) in the guinea pig. J Pharmacol Exp Ther 1998;287:988-995.
19. Rossi GA, Crimi E, Lantero S, et al. Late-phase asthmatic reaction to inhaled allergen in associated with early recruitment of eosinophilis in the airway. Am Rev Respir Dis 1991;144:379-383.
20. Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel antiasthma drugs. Am J Respir Crit Care Med 1998; 157:351-370.